The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

Many natural compounds that act on the human body provide active ingredients for medicines or clues for developing them, and ...

Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, molecular modeling and automated research workflows.

Millions of people live with atrial fibrillation, a racing, uneven heartbeat that can leave you exhausted and scared. Yet it ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

Biopharmaceutical artificial intelligence startup Owkin Inc. said today it’s making a series of autonomous agents focused on ...

Opportunities in RNA Targeting Small Molecule Drug Discovery are driven by advances in RNA biology, structural analysis, and ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

Accelerated drug discovery and development platform Converge Bio Inc. today announced it has raised $25 million in ...

Illumina launched the Billion Cell Atlas to train AI on one billion single cells. AstraZeneca, Merck and Lilly are founding ...

MIT researchers are now turning the prolific Boltz series of models into a software company that promotes open science for AI-guided therapeutics.

Virtual screen of 10,000 proteins and 500 million compounds takes just a day, delivers 2 million small-molecule hits ...